Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Pretta

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|July 15, 2021
BRCA-mutant pancreatic ductal adenocarcinomaEleonora Lai, Pina Ziranu, Dario Spanu, et al.
Seminars in Oncology|December 27, 2023
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspectsSerafina Martella, Minke Lucas, Michele Porcu, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 16, 2020
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenibAndrea Casadei-Gardini, Giulia Rovesti, Vincenzo Dadduzio, et al.
Expert Review of Anticancer Therapy|September 23, 2021
Molecular-driven treatment for biliary tract cancer: the promising turning pointMara Persano, Marco Puzzoni, Pina Ziranu, et al.
International Journal of Molecular Sciences|March 28, 2026
Correction: Ziranu et al. Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 7619Pina Ziranu, Andrea Pretta, Giorgio Saba, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 13, 2022
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatmentAndrea Pretta, Pina Ziranu, Riccardo Giampieri, et al.
Cancers|February 25, 2023
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 ExpressionPina Ziranu, Valentina Aimola, Andrea Pretta, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Estrogen Receptor-Low Positive (ER-Low) Breast Cancer: A Unique Clinical and Pathological EntityGavino Faa, Eleonora Lai, Pina Ziranu, et al.
Cancers|April 27, 2024
CD44: A New Prognostic Marker in Colorectal Cancer?Pina Ziranu, Andrea Pretta, Valentina Aimola, et al.
International Journal of Molecular Sciences|July 1, 2020
Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene ExpressionAna Florencia Vega-Benedetti, Eleonora Loi, Loredana Moi, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|July 15, 2021
BRCA-mutant pancreatic ductal adenocarcinomaEleonora Lai, Pina Ziranu, Dario Spanu, et al.
Seminars in Oncology|December 27, 2023
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspectsSerafina Martella, Minke Lucas, Michele Porcu, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 16, 2020
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenibAndrea Casadei-Gardini, Giulia Rovesti, Vincenzo Dadduzio, et al.
Expert Review of Anticancer Therapy|September 23, 2021
Molecular-driven treatment for biliary tract cancer: the promising turning pointMara Persano, Marco Puzzoni, Pina Ziranu, et al.
International Journal of Molecular Sciences|March 28, 2026
Correction: Ziranu et al. Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 7619Pina Ziranu, Andrea Pretta, Giorgio Saba, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 13, 2022
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatmentAndrea Pretta, Pina Ziranu, Riccardo Giampieri, et al.
Cancers|February 25, 2023
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 ExpressionPina Ziranu, Valentina Aimola, Andrea Pretta, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Estrogen Receptor-Low Positive (ER-Low) Breast Cancer: A Unique Clinical and Pathological EntityGavino Faa, Eleonora Lai, Pina Ziranu, et al.
Cancers|April 27, 2024
CD44: A New Prognostic Marker in Colorectal Cancer?Pina Ziranu, Andrea Pretta, Valentina Aimola, et al.
International Journal of Molecular Sciences|July 1, 2020
Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene ExpressionAna Florencia Vega-Benedetti, Eleonora Loi, Loredana Moi, et al.
Pageof 6